Latest News and Press Releases

SUNNYVALE, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Ooma, Inc., a smart communications platform for businesses and consumers, announced today that – for the sixth year in a row – the company’s...

PHILADELPHIA and OXFORD, United Kingdom, April 02, 2019 (GLOBE NEWSWIRE) --  Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, presented initial safety data...

NEWARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Rain Therapeutics Inc., a privately-held, clinical stage biotechnology company focused on biomarker-driven, small molecule therapeutics for...

RICHMOND, Va., April 02, 2019 (GLOBE NEWSWIRE) -- “Clinical inertia causes diabetes to deteriorate in millions of patients,” said Sidney Chan, CEO of ALR Technologies Inc. (OTCPINK: ALRT), the...

TORONTO, April 02, 2019 (GLOBE NEWSWIRE) -- Toronto, Ontario - Duncan Park Holdings Corporation (the "Company") (TSXV: DPH) announced today that John W. Langmuir has been appointed as Chief...

DALLAS, April 02, 2019 (GLOBE NEWSWIRE) -- Symphony RetailAI, the leading global provider of AI-enabled revenue growth management solutions and customer-centric insights for retailers and CPG...

No Dose-Limiting Toxicities or Serious Adverse Events Reported following Three Once Weekly Doses of Universal, Off-the-Shelf NK Cell Product Candidate New Preclinical Data of Universal,...

HORSHAM, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the “Company”), a medical technology company in Dermatology and Plastic Surgery dedicated to...

--CDX-1140 has achieved good systemic exposure without reaching a maximum tolerated dose to date----Addition of dendritic cell growth factor CDX-301 enhances cytokine response without additive...

SAN FRANCISCO, April 02, 2019 (GLOBE NEWSWIRE) -- Rhumbix, a powerful mobile platform designed for smarter construction sites, has announced their partnership with CMiC, a premier provider of...